|
|
|
|
|
|
Companies > Commercial
|
|
|
The Imalux technology platform, sold under the Niris® trademark, is based on a proprietary application of optical coherence tomography using harmless, near infrared light to provide real-time, high resolution, cross sectional imaging of tissue structures. Niris is a tool to aid in the minimally invasive detection of early stage cancer, guidance of biopsy and surgery, and post-treatment surveillance in a multitude of clinical applications, especially gynecology, urology, GI, and dermatology.
Funders:
Greatbatch, Early Stage Partners, Reservoir Ventures, Medical Growth Fund
|
|
|
|
|